What the company does
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, …
What the weekly tape is saying
GSK closed the latest completed week at 1,984 GBP. The 4-week return is 6.5% and the 12-week return is 1.7%. Trend Signal is inactive, Market Dynamics is -1.05. Setup signature: Balanced read with a 51/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1,957 GBP
- Vs Trend Line
- 1.4%
- Fair Value
- 1,585 GBP
- Vs Fair Value
- 25.2%
- 52W High
- 2,282 GBP
- 52W Low
- 1,288 GBP
- Drawdown
- -13.0%
- Range Position
- 70.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 36
- 52W Active Breadth
- 69.2%
- Sector Scope
- GB Healthcare
- Sector Rank
- 12 of 78
- Sector Percentile
- 85.7%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
GB Healthcare
- Tracked Peers
- 78
- 4W Rank
- 17 of 78
- Avg 1W
- -2.0%
- Avg 4W
- -0.2%
- Trend Breadth
- 38.5%
- Positive MD
- 55.1%
GB Drug Manufacturers - General
- Tracked Peers
- 2
- 4W Rank
- 1 of 2
- Avg 1W
- -0.2%
- Avg 4W
- 2.6%
- Trend Breadth
- 0.0%
- Positive RS
- 50.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.05
- 4W MD Change
- 7.1%
- Relative Strength
- 5.48
- 4W RS Change
- 128.6%
- Expectation
- Undecided
- Probability
- 50.41%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 33.6M
- 13W Average
- 37.8M
- 52W Average
- 41.6M
- Vs 13W
- 0.9x
- Vs 52W
- 0.8x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.6%
- 52W Volatility
- 4.1%
- Upside Weeks
- 27
- Downside Weeks
- 24
- Downside Breadth
- 46.2%
- Avg Gain / Loss
- 3.1% / -2.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- LSE
- Country
- GB
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- GBP
- Market Cap
- 75.5B
Opportunity signals
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Market Dynamics is negative, which weakens the current setup.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1,984 GBP | 2.4% | 1,957 GBP | 1,585 GBP | -1.05 | 5.48 | 33.6M | Off |
| 5 Jun 2026 | 1,938 GBP | 3.0% | 1,950 GBP | 1,581 GBP | -1.17 | 4.28 | 38.6M | Off |
| 29 May 2026 | 1,882 GBP | -1.7% | 1,944 GBP | 1,577 GBP | -1.25 | 1.01 | 38.4M | Off |
| 22 May 2026 | 1,915 GBP | 2.8% | 1,941 GBP | 1,574 GBP | -1.23 | 2.35 | 22.1M | Off |
| 15 May 2026 | 1,862 GBP | 1.1% | 1,931 GBP | 1,570 GBP | -1.12 | 2.40 | 42.4M | Off |
| 8 May 2026 | 1,843 GBP | -3.1% | 1,923 GBP | 1,568 GBP | -0.95 | 1.19 | 37.4M | On |
| 1 May 2026 | 1,901 GBP | -5.9% | 1,916 GBP | 1,565 GBP | -0.66 | 3.27 | 52.0M | On |
| 24 Apr 2026 | 2,020 GBP | -5.8% | 1,907 GBP | 1,562 GBP | -0.43 | 9.75 | 31.4M | On |
| 17 Apr 2026 | 2,144 GBP | -1.5% | 1,889 GBP | 1,559 GBP | -0.23 | 13.70 | 27.2M | On |
| 10 Apr 2026 | 2,176 GBP | 1.5% | 1,867 GBP | 1,554 GBP | -0.19 | 16.63 | 30.1M | On |
| 3 Apr 2026 | 2,144 GBP | 4.6% | 1,845 GBP | 1,550 GBP | -0.11 | 17.27 | 38.2M | On |
| 27 Mar 2026 | 2,049 GBP | 5.0% | 1,823 GBP | 1,546 GBP | -0.03 | 17.73 | 50.8M | On |
| 20 Mar 2026 | 1,950 GBP | -4.0% | 1,803 GBP | 1,542 GBP | 0.29 | 13.05 | 49.2M | On |
| 13 Mar 2026 | 2,031 GBP | -0.3% | 1,787 GBP | 1,539 GBP | 0.72 | 14.06 | 40.5M | On |